A convenient method to differentiate the monoclonal antibodies with differing immunochemical properties

Area of Science:

• Biochemistry
• Immunology
• Toxicology

Background:

• Phospholipase A2 (PLA2) from Naja naja atra is a key toxin.
• Monoclonal antibodies (mAbs) are crucial tools for studying enzyme activity and developing therapeutics.
• Characterizing mAbs against specific toxins like PLA2 is essential for understanding their mechanisms.

Purpose of the Study:

• To develop and characterize monoclonal antibodies against Naja naja atra phospholipase A2 (PLA2).
• To differentiate mAbs based on their ability to inhibit PLA2 enzymatic activity and their binding patterns.
• To investigate the immunochemical properties of mAbs targeting PLA2.

Main Methods:

• Hybridoma technique was used to generate monoclonal antibodies against Naja naja atra PLA2.
• Enzyme immunoassay was employed to assess the binding patterns of mAbs to modified PLA2 derivatives and homologues.
• Enzymatic activity assays were performed to determine the inhibitory effects of the mAbs on PLA2.

Main Results:

• Three mAbs against Naja naja atra PLA2 were successfully prepared.
• Two mAbs (1E531 and 5F92) inhibited PLA2 enzymatic activity, while one (5F6F10) did not.
• mAbs 1E531 and 5F92 exhibited similar binding patterns, distinct from mAb 5F6F10, when tested against modified PLA2 variants.

Conclusions:

• Monoclonal antibodies can be differentiated based on their distinct immunochemical properties and effects on PLA2 activity.
• The characterized mAbs provide valuable tools for further research into Naja naja atra PLA2 structure and function.
• Understanding mAb binding specificities is critical for developing targeted inhibitors or diagnostic tools for snake venom toxins.